FROM OUR EXPERTS
In the summer of 2005, I met several MS patients who were undergoing Solumedrol treatments. I was in the infusion clinic for a release as were several other patients. One patient (I’ll call her Mary), however, was there for a different reason. She had just had a baby.
Before the baby was born, Mary had a plan. She had gone off of her disease-modifying drug (Rebif) when she learned she was pregnant and she planned to breastfeed for a certain period of time before going back on Rebif. The Solumedrol treatment was to ward off any postpartum MS rebounds.
The decision to breastfeed was an important one to Mary as she felt that it was vital to the well-being of her new daughter. But how did Mary decide what drugs to take or not take during that time period?
This week is World Breastfeeding Week and thanks to the LactMed database, offered by the National Library of Medicine, we can research the effect of different drugs and chemicals on lactation.
(With reporting from EurekAlert.org) A new, long-term study of the most popular osteoporosis drug, Fosamax or alendronate sodium , has found extended fracture relief for women who have taken the drug for five years. After that time period has elapsed, women with osteoporosis can discontinue drug use without increasing their fracture risk for as long as five more years after stopping treatment. Researchers from the University of California, San Francisco, published their study on Fosamax (alendronate sodium) in the December 27, 2006 issue of the Journal of the American Medical Association . The research also showed that the fracture relief was not as strong for women at very high risk of spinal fractures , and so these women may benefit from continuing treatment. "This has important implications as it has not been known whether treatment of osteoporosis should be continued indefinitely," said lead author Dennis Black, PhD, professor in the UCSF Department of Epid...
Automobile accidents are the number one cause of death in 16-20 year olds. According to “The Teen Driver” published by the American Academy of Pediatrics, there are 5,500 deaths and 450,000 injuries as a result of motor vehicle accidents involving teenagers. Futher, the article states that teens with ADHD are "2 to 4 times more likely to be injured in a motor vehicle crash than are their peers without ADHD." Additional risks for teens with ADHD include: Have more speeding citations (as many as 3 times more than non-ADHD teens) Are more likely to cause bodily injury in accidents Are more likely to have their driver’s license suspended or revoked Safe driving requires certain skills: attention to detail, the ability to focus and sustain attention. It requires the driver to be disciplined enough to eliminate or ignore certain distractions. For anyone who has driven a car, you know that becoming distracted – even for a ...
You should know
Answers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.